These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9802763)

  • 1. Troglitazone interferes with gemfibrozil's lipid-lowering action.
    Bell DS; Ovalle F
    Diabetes Care; 1998 Nov; 21(11):2028-9. PubMed ID: 9802763
    [No Abstract]   [Full Text] [Related]  

  • 2. The rise and fall of troglitazone.
    Bailey CJ
    Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
    [No Abstract]   [Full Text] [Related]  

  • 3. A treatment for Mr WP: thiazolidinediones after troglitazone.
    Montague CT
    Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible troglitazone-warfarin interaction.
    Plowman BK; Morreale AP
    Am J Health Syst Pharm; 1998 May; 55(10):1071. PubMed ID: 9606460
    [No Abstract]   [Full Text] [Related]  

  • 5. How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy SS
    Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
    [No Abstract]   [Full Text] [Related]  

  • 6. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
    Fujibayashi K; Nagasaka S; Itabashi N; Kawakami A; Nakamura T; Kusaka I; Ishikawa S; Saito T
    Diabetes Care; 1999 Dec; 22(12):2088-9. PubMed ID: 10587851
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

  • 8. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of use of metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes.
    Hays JH; Gorman RT; Shakir KM
    Endocr Pract; 2002; 8(3):177-83. PubMed ID: 12113629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peroxisome proliferator-activated receptors (PPARs) in the vessel wall: new regulators of gene expression in vascular cells].
    Marx N; Hombach V
    Z Kardiol; 2001 Jul; 90(7):470-7. PubMed ID: 11515276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of Troglitazone therapy.
    Bachman KH
    Arch Intern Med; 1998 May; 158(9):1038. PubMed ID: 9616110
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
    Shiomi M; Ito T; Tsukada T; Tsujita Y; Horikoshi H
    Atherosclerosis; 1999 Feb; 142(2):345-53. PubMed ID: 10030386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones.
    Bedoucha M; Atzpodien E; Boelsterli UA
    J Hepatol; 2001 Jul; 35(1):17-23. PubMed ID: 11495036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning to use troglitazone.
    Riddle MC
    Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
    [No Abstract]   [Full Text] [Related]  

  • 15. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders.
    Subramaniam S
    Clin Exp Hypertens; 1999; 21(1-2):121-36. PubMed ID: 10052648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effect and side effect of troglitazone].
    Toyota T; Ueno Y
    Nihon Rinsho; 2000 Feb; 58(2):376-82. PubMed ID: 10707561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
    Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
    Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
    Samraj GP; Kuritzky L; Quillen DM
    Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin-sensitizing agent].
    Yamanouchi T
    Nihon Rinsho; 1999 Mar; 57(3):675-80. PubMed ID: 10199153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.